Overview

Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China

Status:
RECRUITING
Trial end date:
2027-03-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of Prolia on lumbar spine BMD at 12 months.
Phase:
PHASE4
Details
Lead Sponsor:
Amgen
Treatments:
Denosumab